Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BYM338
BYM338
Novartis aims to show strength with muscle wasting drug
Yahoo/Reuters
Fri, 12/6/13 - 10:24 am
muscle wasting
Novartis
sporadic inclusion body myositis
BYM338
MorphoSys
"Breakthrough Therapy" Status Could Hasten Novartis Drug Review
Motley Fool
Wed, 08/21/13 - 09:05 am
Novartis
breakthrough therapies
BYM338
sporadic inclusion body myositis
FDA